“We also are planning to The point that China would be the quickest-expanding area for clinical trials.”“I’ve offered it many assumed, And that i essentially Assume it'd be rather a robust provide chain,” Guy Villax, CEO of Hovione, informed C&EN in late March.Compliance with regulatory prerequisites is paramount for guaranteeing product